Track topics on Twitter Track topics that are important to you
FRANKFURT AM MAIN, Germany, September 23, 2016 /PRNewswire/ --
BASF CEO to head the German Chemical Industry Association
The Annual General Meeting of the German Chemical Industry Association (VCI) in Düsseldorf has elected Dr. Kurt Bock as the VCI's next president. Bock is Chairman of the Executive Board of BASF SE, Ludwigshafen and has been a member of the VCI executive council and board since fall 2011. His two-year term begins on September 24, 2016 and runs as stipulated in the by-laws until the 2018 annual general meeting.
Speaking as the newly elected president, Bock said: "The chemical and pharmaceutical industry is in the midst of radical change. Globalization and digitization are transforming production and business models in our industry. This comes at a time when rapidly growing populations in emerging and developing countries and the need for sustainable development are calling for new solutions. This process of transformation offers huge potential to boost competitiveness and innovation and strengthen Germany's industrial base. Chemical and pharmaceutical industry players have the expertise and the ideas to help shape the necessary technological and societal change in a responsible way. With a sustainable and forward-looking "Chemie 4.0" we can make a major contribution to improving prosperity and quality of life. The best way to realize this opportunity is if all the relevant stakeholders in industry, politics and civil society pull together."
The VCI vice-presidents elected at the meeting are
The president and three vice-presidents constitute the association's executive board.
Please note: You will find photos and a curriculum vitae of Dr. Kurt Bock under: http://www.vci.de/pressefotos
SOURCE The German chemical industry association (VCI)NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...